期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

转移性乳腺癌化疗进展 被引量：5

Advances in Chemotherapy for Metastatic Breast Cancer
下载PDF
导出
摘要 近年来研制了许多治疗乳腺癌的新药 ,并做了大量临床研究 ,取得了较好的疗效。 In recent years,lots of new drugs treating breast cancer have been developed,and a great deal of clinical study has been carried out.The advances in cytotoxic chemotherapy and ongoing efforts to develop novel agents for metastatic breast cancer are reviewed in this paper.
作者 何声秀 吕丽荣
机构地区 威海市立医院肿瘤科
出处 《现代诊断与治疗》 CAS 2002年第3期155-158,共4页 Modern Diagnosis and Treatment
关键词 转移性乳腺癌 化学治疗 化疗药物开发 Metastatic breast cancer Chemotherapy Biologic therapy
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献24

  • 1[1]Andersson M,Madsen EL,Overgaard M,et al.Doxorubicin versus methotrexate both combined with cyclophosphamide,5-fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer-a randomised study with more than 10 years follow-up from the Danish Breast Cancer Cooperative Group.Danish Breast Cancer Cooperative Group(DBCG)[J].Eur J Cancer,1999,35(1):39-46.
  • 2[2]Lyass O,Uziely B,Ben-Yosef R,et al.Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin(Doxil) in metastatic breast carcinoma[J].Cancer,2000,89(5):1037-1047.
  • 3[3]Valero V,Buzdar AU,Theriault RL,et al.Phase Ⅱ trial of liposome-encapsulated doxorubicin,cyclophosphamide,and fluorouracil as first-line therapy in patients with metastatic breast cancer[J].J Clin Oncol,1999,17(5):1425-1434.
  • 4[4]Estaban E,Lacave AJ,Fernandez JL,et al.Phase Ⅲ trial of cyclophosphamide,epirubicin,fluorouracil(CEF) versus cyclophosphamide,mitoxantrone,fluorouracil(CNF) in women with metastatic breast cancer[J].Breast Cancer Res Treat,1999,58(2):141-150.
  • 5[5]Bishop JF,Dewar J,Toner GC,et al.Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer[J].J Clin Oncol,1999,17:2355-2364.
  • 6[6]Paridaens R,Biganzoli L,Bruning P,et al.Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer:a European Organization for Research and Treatment of Cancer Randomized Study with cross-over[J].J Clin Oncol,2000,18(4):724-733.
  • 7[7]Nabholtz JM,Senn HJ,Bezwoda WR,et al.Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy.304 Study Group[J].J Clin Oncol,1999,17(5):1413-1424.
  • 8[8]Sjostrom J,Blomqvist C,Mouridsen H,et al.Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure:a randomised phase Ⅲ study with crossover on progression by the Scandinavian Breast Group[J].Eur J Cancer,1999,35(8):1194-1201.
  • 9[9]Chan S,Friedrichs K,Noel D,et al.Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer.The 303 Study Group[J].J Clin Oncol,1999,17(8):2341-2354.
  • 10[10]Pluzanska A,Pienkowski T,Jelic S,et al.Phase multicenter trial comparing Toxol/doxorubicin(AT) vs 5-fulorouracil/doxorubicin and cyclophosphamide(FAC) as a first line treatment for patient with metastatic breast cancer[J].Breast cancer Res Treat,1999,57:21a.

同被引文献31

引证文献5

二级引证文献10

现代诊断与治疗
2002年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部